CME/CE

Episodes 1-16 of 27

• 

  RestartResume

  Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey

  RestartResume

  Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey

  CME/CE

  Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey

  0.50 credits

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

  • 

    

    Sawsan As-Sanie, MD

  0.50 credits

• 

  RestartResume

  Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences

  RestartResume

  Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences

  MinuteCE®

  Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences

  1.75 program credits

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Linda Bradley, MD

  • 

    

    Samantha Denäe

  1.75 program credits

• 

  RestartResume

  Creating a Practice Environment That Enhances Healthcare Equality for All Patients

  RestartResume

  Creating a Practice Environment That Enhances Healthcare Equality for All Patients

  CME/CE

  Creating a Practice Environment That Enhances Healthcare Equality for All Patients

  0.50 credits

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Linda Bradley, MD

  • 

    

    Melissa Simon, MD

  0.50 credits

• 

  RestartResume

  Pre- and Postoperative Use of GnRH Antagonists

  RestartResume

  Pre- and Postoperative Use of GnRH Antagonists

  MinuteCE®

  Pre- and Postoperative Use of GnRH Antagonists

  1.75 program credits

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

  1.75 program credits

• 

  RestartResume

  It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases

  RestartResume

  It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases

  MinuteCE®

  It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases

  1.75 program credits

  • 

    

    Linda Bradley, MD

  • 

    

    Melissa Simon, MD

  • 

    

    Casey Joe Hinds

  1.75 program credits

• 

  RestartResume

  Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?

  RestartResume

  Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?

  MinuteCE®

  Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?

  1.75 program credits

  • 

    

    Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

  • 

    

    Sawsan As-Sanie, MD

  • 

    

    James A. Simon, MD, CCD, NCMP, IF, FACOG

  1.75 program credits

• 

  RestartResume

  Patient-Centric Tools to Support Shared Decision-Making: Diagnosing and Assessing Endometriosis 

  RestartResume

  Patient-Centric Tools to Support Shared Decision-Making: Diagnosing and Assessing Endometriosis 

  CME/CE

  Patient-Centric Tools to Support Shared Decision-Making: Diagnosing and Assessing Endometriosis 

  0.25 credits

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Linda Bradley, MD

  • 

    

    Melissa Simon, MD

  0.25 credits

• 

  RestartResume

  Strategies to Address Healthcare Disparities in Patients With Endometriosis

  RestartResume

  Strategies to Address Healthcare Disparities in Patients With Endometriosis

  MinuteCE®

  Strategies to Address Healthcare Disparities in Patients With Endometriosis

  1.75 program credits

  • 

    

    Linda Bradley, MD

  • 

    

    Melissa Simon, MD

  1.75 program credits

• 

  RestartResume

  The Integral Role of GnRH Antagonists in the Management of Endometriosis

  RestartResume

  The Integral Role of GnRH Antagonists in the Management of Endometriosis

  MinuteCE®

  The Integral Role of GnRH Antagonists in the Management of Endometriosis

  1.75 program credits

  • 

    

    Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

  • 

    

    Sawsan As-Sanie, MD

  • 

    

    James A. Simon, MD, CCD, NCMP, IF, FACOG

  1.75 program credits

• 

  RestartResume

  Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”

  RestartResume

  Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”

  MinuteCE®

  Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”

  1.75 program credits

  • 

    

    Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

  • 

    

    James A. Simon, MD, CCD, NCMP, IF, FACOG

  1.75 program credits

• 

  RestartResume

  Clinical Considerations for the Diagnosis of Endometriosis

  RestartResume

  Clinical Considerations for the Diagnosis of Endometriosis

  MinuteCE®

  Clinical Considerations for the Diagnosis of Endometriosis

  1.75 program credits

  • 

    

    Linda Bradley, MD

  • 

    

    James A. Simon, MD, CCD, NCMP, IF, FACOG

  1.75 program credits

• 

  RestartResume

  Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis

  RestartResume

  Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis

  MinuteCE®

  Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis

  1.75 program credits

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Linda Bradley, MD

  1.75 program credits

• 

  RestartResume

  The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences

  RestartResume

  The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences

  CME/CE

  The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences

  0.25 credits

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Sawsan As-Sanie, MD

  • 

    

    Linda Bradley, MD

  0.25 credits

• 

  RestartResume

  Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires

  RestartResume

  Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires

  MinuteCE®

  Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires

  1.75 program credits

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

  1.75 program credits

• 

  MinuteCE®

  Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists

  1.75 credits 10 episodes

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

  • 

    

    Sawsan As-Sanie, MD

  • 

    

    Linda Bradley, MD

  • 

    

    James A. Simon, MD, CCD, NCMP, IF, FACOG

  • 

    

    Melissa Simon, MD

  • 

    

    Samantha Denäe

  • 

    

    Casey Joe Hinds

  1.75 credits 10 episodes

• 

  RestartResume

  Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery 

  RestartResume

  Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery 

  CME/CE

  Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery 

  0.50 credits

  • 

    

    Lee P. Shulman, MD, FACMG, FACOG

  • 

    

    Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

  • 

    

    James A. Simon, MD, CCD, NCMP, IF, FACOG

  0.50 credits

• Prev
• 1
• 2
• Next